ArticleBone marrow transplantation2020

Nilotinib in steroid-refractory cGVHD: prospective parallel evaluation of response, according to NIH criteria and exploratory response criteria (GITMO criteria).

A Olivieri et al.PubMed ↗Publisher ↗

No numbers read from the abstract.